K. Matsunaga

Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation.

T. Gondo, Y. Tanizawa, T. Ando, 2010, The Tohoku journal of experimental medicine.